A recap of the top women's health headlines from October 2026, including FDA approval of pritelivir for refractory HSV, ACOG's new menopause guideline, and more.
|Articles|August 3, 2011
Contraception Lecture
Author(s)Fariha Farooq, FCPS
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Reactions to FDA's boxed warning removals for menopausal hormone therapy
2
Top headlines in women's health from October 2026
3
Top video interviews from The Menopause Society 2026 Annual Meeting
4
FDA grants accelerated approval to DNA immunotherapy for adult recurrent respiratory papillomatosis
5